STOCKHOLM, SWEDEN / RankWire.AI / – The 2026 Nobel Prize in Physiology or Medicine has gone to Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries that created optogenetics. The Nobel Assembly at Karolinska Institutet announced the award on October 5. Their work showed how light-sensitive proteins can control nerve-cell activity with high precision. The method now gives researchers a direct way to study how specific brain circuits shape behaviour, memory and emotion.
Hegemann and Nagel traced the approach to channelrhodopsin, a light-sensitive protein found in the single-celled alga Chlamydomonas. When blue light strikes the protein, it opens a channel that lets charged ions enter the cell. That process can generate an electrical impulse. The researchers also showed that cells carrying channelrhodopsin could become sensitive to light, establishing a key step toward using the protein as a biological switch. Their findings connected a basic biological response to a tool that scientists could adapt for other cell types.
Deisseroth then brought the discovery into neuroscience. He introduced the gene for channelrhodopsin into rat nerve cells and used blue light to trigger nerve signals. He published the breakthrough in 2005. Two years later, his work showed that the light-controlled switch could operate in the brains of living mice. The results helped establish optogenetics as a practical method for studying neural circuits with precise control over selected nerve cells.
From algal protein to neuroscience tool
Optogenetics combines genetic targeting with light to activate or inhibit selected cells. Researchers can use it to test the role of defined nerve-cell groups during specific behaviours or brain functions. The Nobel Assembly at Karolinska Institutet said the method has changed how scientists investigate the living brain. Laboratories worldwide now use optogenetics to map circuits linked to movement, learning, memory, emotion and other functions. The technique also lets researchers connect changes in selected cells with observable effects in living animals.
Scientists have also used optogenetics to study neurological and psychiatric disorders. Research has examined brain circuits involved in Parkinson’s disease, epilepsy, depression, addiction and other conditions. Clinical researchers are testing related approaches aimed at restoring sight in people with severe visual impairment. These medical applications remain experimental, while the method’s established impact is strongest as a research tool for probing how cells and circuits work. Researchers continue to use it across neuroscience to examine specific pathways with controlled light stimulation.
Three laureates share the 2026 award
Deisseroth is a professor at Stanford University and an investigator with the Howard Hughes Medical Institute in the United States. Hegemann works at Humboldt University of Berlin, while Nagel is based at the University of Würzburg in Germany. The three laureates will share the 12 million Swedish kronor prize. The medicine award opened the 2026 Nobel announcements, which continue with prizes in physics, chemistry, literature, peace and economic sciences. Each laureate’s work contributed a distinct step to the development of modern optogenetics.
The Nobel Prize recognizes a chain of discoveries that linked basic research in algae with a widely used method in modern neuroscience. Channelrhodopsin supplied the light-sensitive molecular switch, while later work adapted that switch for precise control of nerve cells. Researchers now use optogenetics across neuroscience and other areas of biology. The laureates will receive their Nobel medals and diplomas at the Stockholm award ceremony on December 10. The ceremony falls on the anniversary of Alfred Nobel’s death and follows the annual Nobel Prize tradition.